View Article

Abstract

Urinary Tract Infection (UTI) is one of the most common bacterial infections affecting millions of people worldwide, particularly women. The condition is mainly caused by pathogenic bacteria such as Escherichia coli, which adhere to the urinary tract lining and lead to inflammation and discomfort. Conventional treatment generally involves antibiotics; however, increasing antibiotic resistance and recurrent infections have encouraged the exploration of alternative and supportive therapies. Herbal medicines have gained attention due to their antimicrobial, anti-inflammatory, and diuretic properties. In addition, D?Mannose has shown promising results in preventing bacterial adhesion to the urinary tract walls, thereby reducing the risk of infection. The formulation of a multi-ingredient syrup combining medicinal herbs, urinary alkalizing agents, and D-mannose may provide a synergistic therapeutic effect in the management of UTIs. Urinary alkalizers help maintain optimal urine pH, which can reduce irritation and support urinary tract health. This review discusses the role of herbal ingredients, D-mannose, and alkalizing agents in the formulation of an effective multi-ingredient syrup for the prevention and management of UTIs

Keywords

UTI, Herbal Syrup, D?Mannose, Urinary Alkalizer, Herbal Medicine

Introduction

Urinary Tract Infection (UTI) is one of the most common bacterial infections affecting the urinary system, including the bladder, urethra, ureters, and kidneys. It affects millions of people worldwide each year and is particularly more common in women due to anatomical and physiological factors. The infection is mainly caused by pathogenic bacteria, most commonly Escherichia coli, which colonize the urinary tract and adhere to the epithelial lining, leading to inflammation and discomfort.UTIs are generally characterized by symptoms such as frequent urination, burning sensation during urination, lower abdominal pain, and cloudy or foul-smelling urine. If left untreated, the infection may spread to the kidneys and cause serious complications. Conventional treatment of UTIs usually involves antibiotic therapy; however, the increasing prevalence of antibiotic resistance and recurrent infections has highlighted the need for safer and more effective alternative approaches.Herbal medicines have been widely used in traditional systems of medicine for the management of urinary tract disorders. Many medicinal plants possess antimicrobial, anti-inflammatory, and diuretic properties that may help in reducing infection and promoting urinary health. Additionally, D?Mannose has gained significant attention as a natural compound that can prevent bacterial adhesion to the urinary tract walls, thereby reducing the risk of infection.Urinary alkalizers such as Potassium Citrate also play an important role in maintaining the pH balance of urine and reducing irritation during urination. Therefore, the formulation of a multi-ingredient syrup containing medicinal herbs, D-mannose, and alkalizing agents may provide a synergistic therapeutic approach for the prevention and management of UTIs. This review focuses on the importance of herbal ingredients, the role of D-mannose, and the benefits of urinary alkalizers in the development of an effective multi-ingredient syrup for urinary tract health.Most UTIs are caused by the bacterium Escherichia coli, which normally lives in the intestinal tract. These bacteria can travel from the anal area to the urethra and then move into the bladder, where they grow and cause infection.UTI can occur due to several reasons, such asPoor personal hygieneHolding urine for a long timeLow water intakeWeak immune systemSexual activityUse of urinary cathetersWhen bacteria enter the urinary tract, they attach to the lining of the bladder and urethra. This causes inflammation, irritation, and symptoms such as burning during urination, frequent urination, and lower abdominal pain.If the infection is not treated in time, it can spread from the bladder to the kidneys and cause more serious health problems.Urinary alkalizers play an important role in reducing discomfort associated with UTIs. During infection, urine may become more acidic, which can increase irritation and burning sensation during urination. Alkalizing agents help increase the pH of urine, making it less acidic and more comfortable for the patient.A commonly used alkalizing agent is Potassium Citrate, which helps neutralize acidic urine and reduce urinary irritation. Alkalizers also create a urinary environment that may help limit bacterial growth and improve patient comfort.

Epidemiology of UTI

Urinary Tract Infection (UTI) is one of the most common bacterial infections affecting people worldwide. It can occur in individuals of all ages, including children, adults, and the elderly. UTIs represent a major public health concern because of their high prevalence and frequent recurrence. The most common causative organism responsible for UTIs is Escherichia coli, which accounts for the majority of community-acquired infections. Thesebacteria usually originate from the intestinal tract and enter the urinary system through the urethra.UTIs are also common in hospitalized patients, especially those using urinary catheters. Risk factors include poor hygiene, sexual activity, diabetes, pregnancy, and weakened immune systems. In older adults, UTIs are more frequent due to decreased immunity and other underlying health conditions.Because of the high incidence and recurrence rate of UTIs, effective prevention and management strategies are essential. This has increased interest in alternative therapies such as herbal formulations and supportive agents like D-Mannose and urinary alkalizers.

Pathophysiology

Follows an upward trend. Women’s UTIs are caused by Faecal flora uropathogens. They infiltrate the vaginal Introitus and displace various species that are naturally Present. One of the most important early stages in the Resulting repetitive UTIs appears to be the colonisation Of the vaginal introitus by E. coli. The urethra serves as The principal route for most uropathogens to enter the  bladder.The pathophysiology of UTI mainly involves the entry, colonization, and multiplication of pathogenic microorganisms in the urinary tract. In most cases, UTIs occur when bacteria from the gastrointestinal tract enter the urethra and ascend into the bladder.The most common causative organism is Escherichia coli. These bacteria possess special surface structures known as fimbriae or adhesins, which allow them to attach firmly to the epithelial cells lining the urinary tract. This attachment prevents the bacteria from being flushed out during urination.Once attached, the bacteria multiply and trigger an immune response in the body. The immune system releases inflammatory mediators and white blood cells to fight the infection. This inflammatory response leads to swelling and irritation of the urinary tract lining. Understanding the pathophysiology of UTIs is important for developing effective treatment strategies, including herbal therapies, urinary alkalizers, and supportive agents such as D-Mannose that help prevent bacterial adhesion in the urinary tract.

Mechanism of action

Urinary tract infection (UTI) occurs when pathogenic microorganisms, mainly bacteria, enter and multiply within the urinary tract. The most common causative organism is Escherichia coli, which is responsible for nearly 80–90% of uncomplicated UTIs. Other microorganisms such as Klebsiella pneumoniae, Proteus mirabilis, Staphylococcus saprophyticus, and Enterococcus faecalis may also cause infection.The infection usually begins when bacteria from the gastrointestinal tract reach the urethral opening. Poor is a hygiene, sexual activity, catheterization, or a weakened immune system can facilitate the entry of these microorganisms into the urinary tract.After entering the urethra, the bacteria begin to multiply and colonize the epithelial cells lining the urethra. At this stage, if the or body’s natural defense mechanisms such as urine flow and immune response are unable to eliminate the bacteria, the infection progresses further.Once attached, bacteria can migrate upward through the urinary tract. This ascending infection may spread from the urethra to the bladder, causing cystitis, and in severe cases may reach the ureters and kidneys, leading to more serious infections such as pyelonephritis.

Urinary Alkalizer

Urinary alkalizers are substances that increase the pH of urine, making it less acidic and more alkaline. In normal conditions, urine has a pH ranging from about 4.5 to 8. During urinary tract infections (UTIs), urine often becomes more acidic, which can worsen symptoms such as burning sensation, irritation, and pain during urination.Urinary alkalizers help neutralize the acidity of urine and provide symptomatic relief. By increasing the urinary pH, these agents reduce irritation of the urinary tract lining and decrease discomfort associated with urination. This is particularly helpful in relieving dysuria (painful urination), which is a common symptom of UTI.UTIs are most commonly caused by bacteria such as Escherichia coli, which infect the urinary tract and lead to inflammation of the bladder and urethra. Acidic urine can aggravate the inflamed tissues, increasing the sensation of burning and discomfort. Urinary alkalizers reduce this irritation by creating a more alkaline environment in the urine.Common urinary alkalizing agents include Potassium citrate, Sodium citrate, and Sodiumbicarbonate. These compounds are metabolized in the body to produce bicarbonate ions, which help neutralize acids and raise the pH of urine.In addition to relieving symptoms, urinary alkalizers may also help reduce the risk of crystal formation in the urinary tract by maintaining a more favorable urinary pH. In many formulations for UTI management, urinary alkalizers are combined with herbal ingredients and compounds like D-mannose to provide both symptomatic relief and supportive therapeutic effects.

Herbal Drug in Uti Treatments

Urinary tract infection (UTI) is a common bacterial infection of the urinary system, mainly caused by pathogens such as Escherichia coli. Although antibiotics are widely used for treatment, the frequent use of antibiotics can lead to antimicrobial resistance and recurrence of infection. Therefore, herbal drugs are increasingly being explored as alternative or supportive therapies in the management of UTI.Herbal medicines contain bioactive compounds that exhibit antimicrobial, anti-inflammatory, antioxidant, and diuretic properties. These activities help inhibit bacterial growth, reduce inflammation of the urinary tract, and promote the flushing of pathogens through increased urine flow.One of the most widely studied herbal remedies for UTI is Cranberry (Vaccinium macrocarpon).Cranberry contains proanthocyanidins that prevent the adhesion ofbacteria, especially Escherichia coli, to the lining of the urinary tract. This mechanism reduces bacterial colonization and helps prevent infection.Another important herb is Tribulus terrestris, commonly known as Gokhru. It is traditionally used in Ayurvedic medicine for urinary disorders. It possesses diuretic and antimicrobial properties that help in flushing out bacteria and relieving symptoms such as burning urination. Similarly, Azadirachta indica (Neem) exhibits significant antibacterial and antifungal activities. Neem extracts help inhibit the growth of several pathogenic microorganisms responsible for urinary infections.Herbal drugs offer several advantages in UTI management, including fewer side effects, natural origin, and multiple mechanisms of action. When used in combination with agents such as D-Mannose and urinary alkalizers, herbal formulations may provide enhanced therapeutic benefits by preventing bacterial adhesion, reducing inflammation, and maintaining a favorable urinary pH.In conclusion, herbal drugs play an important role in the prevention and supportive treatment of UTI. Their antimicrobial and diuretic properties make them promising components in multi-ingredient formulations designed for urinary tract infections.

Herbal Medicines as Possibilities

Scientific suggestions on the “safety and effectiveness Of natural drugs” were announced by the World Health Organisation in 199314. They made it proper that a Drug’s historical use was a trustworthy predictor of its Safety in the absence of any contradictory scientific.Facts15. One important source of novel antibiotic Development has been the extensiveuse of herbal Treatments in traditional medicine.

Cranberry (Vaccinium macrocarpon or Vacinnium oxycoccus)

Because concentrated cranberry extract in cranberry juice keeps germs away from adhering to the surface of the urinary tract, it is a popular home treatment for UTIs. It therefore lowers the likelihood of developing UTIs again. It contains a flavonoid calle proanthocyanidin-A, which has an antibacterial action. It strengthens the immune sys eases the discomfort associated with urinating, helps control the PH of urine, and activa macrophages to aid in the healing of wounds and the reduction of inflammation16. The likelihood of asymptomatic bacteriuria is decreased. These products are recommended by the Canadian Society of Obstetricians and Gynaecologists as a prophylactic against recurrent UTI.

Cranberry

 

 

Gokhru(Tribulus terrestris)

Tribulus terrestris, commonly known as Gokhru, is an important medicinal plant used in traditional systems such as Ayurveda for the treatment of urinary tractBecause of these beneficial effects, Gokhru is frequently used as a key ingredient in herbal formulations, syrups, and urinary tonics designed for the prevention and supportive treatment of UTI. Gokhru contains several bioactive compounds including saponins, flavonoids, alkaloids, and tannins. These phytochemicals contribute to its therapeutic effects. The plant helps increase urine output (diuretic effect), which assists in flushing out harmful bacteria from the urinary tract.One of the main causes of UTI is the bacterium Escherichia coli. Studies have shown that extracts of Tribulus terrestris exhibit antimicrobial activity against several pathogenic microorganisms, thereby helping reduce bacterial growth in the urinary system.Additionally, Gokhru possesses anti-inflammatory properties, which help reduce irritation, burning sensation, and swelling of the urinary tract that commonly occur during UTI. It is also known to support kidney and bladder health by improving urinary flow and maintaining normal urinary function.Because of these beneficial effects, Gokhru is frequently used as a key ingredient in herbal formulations, syrups, and urinary tonics designed for the prevention and supportive treatment of UTI. When combined with other herbal drugs and agents such as D-Mannose and urinary alkalizers, it can provide a synergistic therapeutic effect in managing urinary tract infections.

 

 

Gokhru

D mannose

D?Mannose is a naturally occurring simple sugar that is increasingly used in the prevention and management of urinary tract infections (UTIs). It is structurally similar to glucose and is found in small amounts in fruits such as Cranberry and apples. D-Mannose has gained attention because it can help prevent bacterial adhesion in the urinary tract without the use of antibiotics.The most common cause of UTI is the bacterium Escherichia coli. These bacteria attach the lining of the urinary tract using tiny hair-like structures called fimbriae. D?Mannose works by binding to these fimbriae on the bacterial surface. When bacteria attach to D-mannose molecules instead of the urinary tract wall, they are unable to adhere to the bladder lining and are easily flushed out of the body through urine. In herbal and nutraceutical formulations, D?Mannose is frequently combined with medicinal herbs and urinary alkalizers. This combination provides multiple benefits such as preventing bacterial adhesion, reducing inflammation, and improving urinary comfort.

 

 

D mannose

Neem(Azadirachta indica)

Neem (Azadirachta indica) is a well-known medicinal plant widely used in traditional medicine due to its strong antimicrobial, anti-inflammatory, and antioxidant properties. Neem contains several bioactive compounds such as azadirachtin, nimbidin, flavonoids, and tannins, which contribute to its therapeutic effects. In the management of Urinary Tract Infection, neem extracts have shown significant antibacterial activity against uropathogenic microorganisms, particularly Escherichia coli, which is the primary causative agent of most UTIs. These compounds inhibit the growth and adhesion of bacteria in the urinary tract, thereby helping to reduce infection. Additionally, neem possesses anti-inflammatory properties that can help reduce irritation and inflammation of the bladder and urinary tract lining, which are common symptoms of UTIs. The antioxidant activity of neem also protects urinary tract tissues from oxidative stress and supports faster recovery. Due to these pharmacological properties, neem can be considered a valuable herbal ingredient in the formulation of multi-ingredient herbal syrups intended for the management of urinary tract infections.

 

 

 

Neem

Garlic (Allium sativum)

Because it can increase immunity and reduce inflammation, garlic is well known for its antimicrobial qualities. It consists of sulphur. Allicin is an excellent source of the potent antioxidant glutathione and helps with detoxification28. Garlic extract is a treatment for recurrent UTIs. Additionally, reviews indicate that using it lessens impulses to urinate frequency of urine and pain in the pubic area.

 

 

Garlic

Benefits of Multi Ingredients Syrup

A multi-ingredient herbal syrup formulated for the management of Urinary Tract Infection contains several natural components that provide antimicrobial, anti-inflammatory, and urinary alkalizing effects. The combination of herbal extracts and supportive compounds helps in reducing infection, relieving symptoms, and improving urinary health.One of the important herbal ingredients is Tribulus terrestris (Gokhru), which is widely used in traditional medicine for the treatment of urinary disorders. It possesses significant diuretic and anti-inflammatory properties that help increase urine flow and facilitate the flushing of bacteria from the urinary tract. Another beneficial herb is Azadirachta indica (Neem), known for its strong antibacterial and antioxidant activities. Neem contains bioactive compounds that inhibit the growth of pathogenic microorganisms and reduceinflammation within the urinary tract.

DISCUSSION

Various parts of the urinary tract system could harbour The bacteria that cause urinary tract infections. The Infection listed by doctors in poor nations is UTI.

Diabetes, renal failure, long-term corticosteroid therapy, And the use of immune-suppressive medications For autoimmune illnesses are long-term factors that Increase the risk of UTI. The main problem is urinary Obstruction brought on by prostatic hypertrophy, Tumours, bladder catheterization, and pregnancy Klebsiella species, E. coli, and E. faecalis are the Main offenders. UTIs are caused by uncommon Bacteria found in subtropical regions, including Proteus, Staphylococcus, and Pseudomonas variola. Natural medication is inexpensive, safe, and simple To take. The main benefit of these herbal medicines Is that they do not cause bacterial resistance. These Natural therapies can help with the resistance issue that Results from using standard treatments. No reports of Microbial susceptibility to herbal medicine have been Produced to date, perhaps due to the diverse array of Phytochemical components found in medicinal plants, Which are primarily responsible for both their positive And synergistic effects. The phytochemicals used to Treat urinary tract infections were the only topic of this Review. Research is currently being done to pinpoint The precise processes via which the phytochemicals In these herbs affect UTIs. To fully understand these Phytochemical modes of action, more investigation Is required. To determine which phytoconstituents Are responsible for treating UTIs, more research is Required. Thus, you must carry out additional research On genetics and develop techniques to ascertain How phytoconstituents work to eradicate harmful Microorganism.

CONCLUSION

Among the most prevalent illnesses in both Industrialized and developing nations, urinary tract Infections are more common in women than in men. Depending on the extremity of the infection, different Drugs are used to treat UTIs. However, the bacteria Linked to UTIs are becoming more tough for medical Experts to treat as a result of antibiotic treatment Resistance. One kind of alternative therapy that has Been proven to be one of the most effective therapeutic Approaches and is regarded as a godsend for treating UTIs is herbal medicine. Modern methods like RNA Sequencing, which studies bacteria directly to identify Urinary tract infections, and appropriate evidence of Barcoding technology’s use to identify medicinal plants And their bioactive components which bolster those Plants’ antibacterial qualities need, nevertheless, to receive greater attention. The formulation of a multi-ingredient herbal syrup containing medicinal plants such as Tribulus terrestris, Azadirachta indica, and Boerhavia diffusa, along with supportive compounds like D-Mannose, provides a promising strategy for the management of UTIs. These ingredients possess important properties such as antimicrobial, anti-inflammatory, diuretic, and antioxidant effects that help reduce bacterial growth, flush out pathogens from the urinary tract, and relieve symptoms. In addition, urinary alkalizers such as Potassium citrate help maintain an appropriate urinary pH, thereby reducing irritation and burning sensation during urination.

REFERENCES

  1. Oyelami OA, Agbakwuru EA, Adeyemi LA, Adedeji GB. The effectiveness of grapefruit (Citrus paradisi) seeds in treating urinary tract infections. The Journal of Alternative and Complementary Medicine. 2005; 11(2):369-71.
  2. Griebling TL. Urologic diseases in America project: Trends in resource use for urinary tract infections in women. Journal of Urology. 2005; 173(4):1281-7.
  3. Foxman B. Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs. American Journal of Medicine. 2002; 113(1):5-13..org/10.1016/S0002-9343(02)01054-9
  4. Schrier RW. Diseases of the kidney and urinary tract. Lippincott Williams and Wilkins; 2007.
  5. Finnell SM, Carroll AE, Downs SM. Diagnosis and Management of an initial UTI in febrile infants and young Children. Pediatrics. 2011; 128(3):e749-70.. Org/10.1542/peds.2011-1332
  6. Barnett BJ, Stephens DS. Urinary tract infection: An Overview. American Journal of the Medical Sciences. 1997; 314(4):245-9. 9629(15)40208-3
  7. Nicolle L. Best pharmacological practice: Urinary tract Infections. Expert Opinion on Pharmacotherapy. 2003; 4(5):693-704.
  8. Nicolle LE. Uncomplicated urinary tract infection in adults Including uncomplicated pyelonephritis. Urologic Clinics of North America. 2008; 35(1):1-2..Ucl.2007.09.004
  9. Lane DR, Takhar SS. Diagnosis and management of urinary Tract infection and pyelonephritis. Emergency Medicine Clinics. 2011; 29(3):539-52..Emc.2011.04.001
  10. Salvatore S, Salvatore S, Cattoni E, Siesto G, Serati M, Sorice P, et al. Urinary tract infections in women. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2011; 156(2):131-6..Ejogrb.2011.01.028
  11. Soulsby EJ. Resistance to antimicrobials in humans and Animals. Bmj. 2005; 331(7527):1219-20..Org/10.1136/bmj.331.7527.1219
  12. Neu HC. The crisis in antibiotic resistance. Science. 1992; 257(5073):1064-73. Science.257.5073.1064
  13. Geneva WH. Traditional medicine-growing needs and Potential. WHO Policy Perspectives Med. 2002; 2:1-6.
  14. Cowan MM. Plant products as antimicrobial agents. Clinical Microbiology Reviews. 1999; 12(4):564-82. https://Doi.org/10.1128/CMR.12.4.564
  15. Basile A, Sorbo S, Giordano S, Ricciardi L, Ferrara S, Montesano D, et al. Antibacterial and allelophatic activity Of Castanea sativa Mill. Leaves. Fitoterapia. 2000; 71:110-6
  1. 16.Fazly Bazzaz BS, Sarabandi S, Khameneh B, Hosseinzadeh H (2016) Efect Of catechins, green tea extract and methylxanthines in combination With gentamicin against Staphylococcus aureus and Pseudomonas aer-Uginosa: combination therapy against resistant bacteria. J Pharmacop-Uncture 19:312–318
  1. Baker JH, Qiu J, Grine K (2018) Role of complementary and alternative Therapies in infectious disease. Prim Care Clin Of Pract 45:533–539
  2. Mantzorou M, Giaginis C (2018) Cranberry consumption against urinary Tract infections: clinical state-of-the-art and future perspectives. Curr
  1. Pharm Biotechnol 19:1049–1063
  1. Poulios E, Vasios GK, Psara E, Giaginis C (2020) Medicinal plants Consumption against urinary tract infections: a narrative review of the Current evidence. Expert Rev Anti Infect Ther 2020:1–10
  2. Loubet P, Ranfaing J, Dinh A, Dunyach-Remy C, Bernard L, Bruyère F, Lavigne J-P, Sotto A (2020) Alternative therapeutic options to antibiotics For the treatment of urinary tract infections. Front Microbiol 11:1
  3. Farhadi F, Khameneh B, Iranshahi M, Iranshahy M (2019) Antibacterial Activity of favonoids and their structure-activity relationship: an update Review. Phytother Res 33:13–40
  4. Shaheen G, Akram M, Jabeen F, Ali Shah SM, Munir N, Daniyal M, Riaz M, Tahir IM, Ghauri AO, Sultana S, Zainab R, Khan M (2019) Therapeutic Potential of medicinal plants for the management of urinary tract infec-Tion: a systematic review. Clin Exp Pharmacol Physiol 46:613–624
  5. Yarnell E (2002) Botanical medicines for the urinary tract. World J Urol 20:285–293
  6. Bag A, Bhattacharyya S, Chattopadhyay R (2008) Medicinal plants and Urinary tract infections: an update. Phcog Rev 2:277
  7. Marino A, Bellinghieri V, Nostro A, Miceli N, Taviano MF, Guvenc A, Bisig-Nano G (2010) In vitro efect of branch extracts of Juniperus species From Turkey on Staphylococcus aureus bioflm. FEMS Immunol Med Microbiol 59:470–476
  8. Schilcher H (1995) Juniper berry oil in diseases of the eferent urinary Tract? Med Monatsschr Pharm 18:198–199
  9. Pepeljnjak S, Kosalec I, Kalodera Z, Blazevic N (2005) Antimicrobial activ-Ity of juniper berry essential oil (Juniperus communis L., Cupressaceae). Acta Pharm 55:417–422
  10. Howell AB, Foxman B (2002) Cranberry juice and adhesion of antibiotic-Resistant uropathogens. JAMA 287:3082–3083
  11. Burger O, Ofek I, Tabak M, Weiss EI, Sharon N, Neeman I (2000) A high Molecular mass constituent of cranberry juice inhibits Helicobacter Pylori adhesion to human gastric mucus. FEMS Immunol Med Microbiol 29:295–301
  12. Di Martino P, Agniel R, David K, Templer C, Gaillard JL, Denys P, Botto H (2006) Reduction of Escherichia coli adherence to uroepithelial bladder Cells after consumption of cranberry juice: a double-blind randomized Placebo-controlled cross-over trial. World J Urol 24:21–27
  13. Tao Y, Pinzon-Arango PA, Howell AB, Camesano TA (2011) Oral con-Sumption of cranberry juice cocktail inhibits molecular-scale adhesion Of clinical uropathogenic Escherichia coli. J Med Food 14:739–745
  14. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010;340:c2096.
  15. Fagan M, Lindbæk M, Grude N, et al. Antibiotic resistance patterns of bacteria causing urinary tract infections in the elderly living in nursing homes versus the elderly living at home: an observational study. BMC Geriatr. 2015;15:98
  16. Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2012;10:CD001321.
  17. Juthani-Mehta M, Van Ness PH, Bianco L, et al. Effect of cranberry capsules on bacteriuria plus pyuria among older women in nursing homes: a randomized clinical trial. JAMA. 2016;316(18):1879–1887.
  18. Nicolle LE. Cranberry for prevention of urinary tract infection? Time to move on. JAMA. 2016;316(18):1873–1874.
  19. Taha Neto KA, Nogueira Castilho L, Reis LO. Oral vaccine (OM-89) in the recurrent urinary tract infection prophylaxis: a realistic systematic review with meta-analysis. Actas Urol Esp. 2016;40(4):203–208.
  20. Perrotta C, Aznar M, Mejia R, Albert X, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev. 2008;(2):CD005131
  21. Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med. 1993;329(11):753–756.
  22. Eriksen B. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol. 1999;180(5):1072–1079.

Reference

  1. Oyelami OA, Agbakwuru EA, Adeyemi LA, Adedeji GB. The effectiveness of grapefruit (Citrus paradisi) seeds in treating urinary tract infections. The Journal of Alternative and Complementary Medicine. 2005; 11(2):369-71.
  2. Griebling TL. Urologic diseases in America project: Trends in resource use for urinary tract infections in women. Journal of Urology. 2005; 173(4):1281-7.
  3. Foxman B. Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs. American Journal of Medicine. 2002; 113(1):5-13..org/10.1016/S0002-9343(02)01054-9
  4. Schrier RW. Diseases of the kidney and urinary tract. Lippincott Williams and Wilkins; 2007.
  5. Finnell SM, Carroll AE, Downs SM. Diagnosis and Management of an initial UTI in febrile infants and young Children. Pediatrics. 2011; 128(3):e749-70.. Org/10.1542/peds.2011-1332
  6. Barnett BJ, Stephens DS. Urinary tract infection: An Overview. American Journal of the Medical Sciences. 1997; 314(4):245-9. 9629(15)40208-3
  7. Nicolle L. Best pharmacological practice: Urinary tract Infections. Expert Opinion on Pharmacotherapy. 2003; 4(5):693-704.
  8. Nicolle LE. Uncomplicated urinary tract infection in adults Including uncomplicated pyelonephritis. Urologic Clinics of North America. 2008; 35(1):1-2..Ucl.2007.09.004
  9. Lane DR, Takhar SS. Diagnosis and management of urinary Tract infection and pyelonephritis. Emergency Medicine Clinics. 2011; 29(3):539-52..Emc.2011.04.001
  10. Salvatore S, Salvatore S, Cattoni E, Siesto G, Serati M, Sorice P, et al. Urinary tract infections in women. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2011; 156(2):131-6..Ejogrb.2011.01.028
  11. Soulsby EJ. Resistance to antimicrobials in humans and Animals. Bmj. 2005; 331(7527):1219-20..Org/10.1136/bmj.331.7527.1219
  12. Neu HC. The crisis in antibiotic resistance. Science. 1992; 257(5073):1064-73. Science.257.5073.1064
  13. Geneva WH. Traditional medicine-growing needs and Potential. WHO Policy Perspectives Med. 2002; 2:1-6.
  14. Cowan MM. Plant products as antimicrobial agents. Clinical Microbiology Reviews. 1999; 12(4):564-82. https://Doi.org/10.1128/CMR.12.4.564
  15. Basile A, Sorbo S, Giordano S, Ricciardi L, Ferrara S, Montesano D, et al. Antibacterial and allelophatic activity Of Castanea sativa Mill. Leaves. Fitoterapia. 2000; 71:110-6
  1. 16.Fazly Bazzaz BS, Sarabandi S, Khameneh B, Hosseinzadeh H (2016) Efect Of catechins, green tea extract and methylxanthines in combination With gentamicin against Staphylococcus aureus and Pseudomonas aer-Uginosa: combination therapy against resistant bacteria. J Pharmacop-Uncture 19:312–318
  1. Baker JH, Qiu J, Grine K (2018) Role of complementary and alternative Therapies in infectious disease. Prim Care Clin Of Pract 45:533–539
  2. Mantzorou M, Giaginis C (2018) Cranberry consumption against urinary Tract infections: clinical state-of-the-art and future perspectives. Curr
  1. Pharm Biotechnol 19:1049–1063
  1. Poulios E, Vasios GK, Psara E, Giaginis C (2020) Medicinal plants Consumption against urinary tract infections: a narrative review of the Current evidence. Expert Rev Anti Infect Ther 2020:1–10
  2. Loubet P, Ranfaing J, Dinh A, Dunyach-Remy C, Bernard L, Bruyère F, Lavigne J-P, Sotto A (2020) Alternative therapeutic options to antibiotics For the treatment of urinary tract infections. Front Microbiol 11:1
  3. Farhadi F, Khameneh B, Iranshahi M, Iranshahy M (2019) Antibacterial Activity of favonoids and their structure-activity relationship: an update Review. Phytother Res 33:13–40
  4. Shaheen G, Akram M, Jabeen F, Ali Shah SM, Munir N, Daniyal M, Riaz M, Tahir IM, Ghauri AO, Sultana S, Zainab R, Khan M (2019) Therapeutic Potential of medicinal plants for the management of urinary tract infec-Tion: a systematic review. Clin Exp Pharmacol Physiol 46:613–624
  5. Yarnell E (2002) Botanical medicines for the urinary tract. World J Urol 20:285–293
  6. Bag A, Bhattacharyya S, Chattopadhyay R (2008) Medicinal plants and Urinary tract infections: an update. Phcog Rev 2:277
  7. Marino A, Bellinghieri V, Nostro A, Miceli N, Taviano MF, Guvenc A, Bisig-Nano G (2010) In vitro efect of branch extracts of Juniperus species From Turkey on Staphylococcus aureus bioflm. FEMS Immunol Med Microbiol 59:470–476
  8. Schilcher H (1995) Juniper berry oil in diseases of the eferent urinary Tract? Med Monatsschr Pharm 18:198–199
  9. Pepeljnjak S, Kosalec I, Kalodera Z, Blazevic N (2005) Antimicrobial activ-Ity of juniper berry essential oil (Juniperus communis L., Cupressaceae). Acta Pharm 55:417–422
  10. Howell AB, Foxman B (2002) Cranberry juice and adhesion of antibiotic-Resistant uropathogens. JAMA 287:3082–3083
  11. Burger O, Ofek I, Tabak M, Weiss EI, Sharon N, Neeman I (2000) A high Molecular mass constituent of cranberry juice inhibits Helicobacter Pylori adhesion to human gastric mucus. FEMS Immunol Med Microbiol 29:295–301
  12. Di Martino P, Agniel R, David K, Templer C, Gaillard JL, Denys P, Botto H (2006) Reduction of Escherichia coli adherence to uroepithelial bladder Cells after consumption of cranberry juice: a double-blind randomized Placebo-controlled cross-over trial. World J Urol 24:21–27
  13. Tao Y, Pinzon-Arango PA, Howell AB, Camesano TA (2011) Oral con-Sumption of cranberry juice cocktail inhibits molecular-scale adhesion Of clinical uropathogenic Escherichia coli. J Med Food 14:739–745
  14. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010;340:c2096.
  15. Fagan M, Lindbæk M, Grude N, et al. Antibiotic resistance patterns of bacteria causing urinary tract infections in the elderly living in nursing homes versus the elderly living at home: an observational study. BMC Geriatr. 2015;15:98
  16. Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2012;10:CD001321.
  17. Juthani-Mehta M, Van Ness PH, Bianco L, et al. Effect of cranberry capsules on bacteriuria plus pyuria among older women in nursing homes: a randomized clinical trial. JAMA. 2016;316(18):1879–1887.
  18. Nicolle LE. Cranberry for prevention of urinary tract infection? Time to move on. JAMA. 2016;316(18):1873–1874.
  19. Taha Neto KA, Nogueira Castilho L, Reis LO. Oral vaccine (OM-89) in the recurrent urinary tract infection prophylaxis: a realistic systematic review with meta-analysis. Actas Urol Esp. 2016;40(4):203–208.
  20. Perrotta C, Aznar M, Mejia R, Albert X, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev. 2008;(2):CD005131
  21. Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med. 1993;329(11):753–756.
  22. Eriksen B. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol. 1999;180(5):1072–1079.

Photo
Shahabuddin alam
Corresponding author

Rungta Institute of Pharmaceutical Science, Kohka kurud bhiali, Chhattisgarh.

Photo
Aftab alam
Co-author

Rungta Institute of Pharmaceutical Science, Kohka kurud bhiali, Chhattisgarh.

Photo
Anish singh
Co-author

Rungta Institute of Pharmaceutical Science, Kohka kurud bhiali, Chhattisgarh.

Photo
Moin khan
Co-author

Rungta Institute of Pharmaceutical Science, Kohka kurud bhiali, Chhattisgarh.

Shahabuddin alam, Aftab alam, Anish singh, Moin khan, Formulation of a Multi Ingredients Syrup for UTI and alkalizer Benefits of herbs and D-mannose, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 3, 3028-3037, https://doi.org/10.5281/zenodo.19203289

More related articles
Antibiotic Use and Resistance: Mechanisms, Trends,...
Preethi V., Poovarasan S., P. Monika, ...
Unveiling the Hepatoprotective Potential of Casear...
Ashwini Helaskar , Dr. Karna Khavane , Aditi Mishra, ...
Anti-Inflammatory Activity of Solanum Surattense F...
Sonali Borde , Dr. Karna Khavane, Aditi Mishra , ...
A Collective Overview of the Phytoconstituents and Pharmacological Actions of Sa...
Manjula G S, John Mithi, Syed Sagheer Ahmed, Dr. Rupesh Kumar M., ...
Phytopharmacological properties of Origanum vulgare: A Review ...
Sandhya verma, Dr. Sunil Kumar Jaiswal, Harsh Shukla, Riya Raj, ...
Community Perspectives Assessing And Addressing Covid 19 Vaccine Myths In Daksh...
Aravind babu c, Satish S., Ramakrishna Shabaraya A., ...
Related Articles
Formulation And Evolution of Anti-Hemorrhoidal Cream by Using Ricinus Communis L...
Abhay Shinde, Anand Shinde, Ganesh Shinde, Mohini Shinde, Priyanka Shinde, Ashwini Gaikwad, ...
Advances in Small Molecule Inhibitors for Cancer Inflammation and Autoimmune Dis...
Aditi Jyotishi, Roshani Bhavsar, Roshani Bhavsar, Ashvini Patmase, Shubham Ahir, Kamran Ahmad Shaikh...
A review of eczema: current therapies and emerging treatments ...
Sakshi Sharma, Anchal Sankhyan, Dr. Dev Prakash Dahiya, Shelly, Indu, ...
The Role of Antiplatelet Agents in Clinical Practice: Mechanism of Action, Indic...
Stephy Ponnachan, J. S. Venkatesh, Shrikanth Godi, Sraddha R., ...
More related articles
Unveiling the Hepatoprotective Potential of Casearia Graveolens: A Comprehensive...
Ashwini Helaskar , Dr. Karna Khavane , Aditi Mishra, ...
Anti-Inflammatory Activity of Solanum Surattense Fruits...
Sonali Borde , Dr. Karna Khavane, Aditi Mishra , ...